Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 47

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 47
---
 3,125,000 shares underlying the Units (assuming the sale of all securities offered hereby, at the fixed public offering price of $3.20 per Unit, and assuming no exercise of the IPO Warrants issued in connection with this offering), after deducting estimated offering expenses payable by us, our as adjusted net tangible book value as of September 30, 2024 would have been approximately $10.1 million, or approximately $0.16 per share. This represents an immediate increase in net tangible book value of approximately $0.07 per share to existing stockholders and an immediate dilution of approximately $3.04 per share to new investors purchasing Units in this offering. The following table illustrates this per share dilution:

| Assumed initial public offering price per Unit                                                             |     |   |       |   |     | $ | 3.20 |
| Historical net tangible book value per share as of September 30, 2024                                      |     | $ |  0.10 |   |     |   |      |
| Decrease in net tangible book value per share attributable to the pro forma adjustments described above    |     |   | (0.01 | ) |     |   |      |
| Pro forma net tangible book value per share                                                                |     | $ |  0.09 |   |     |   |      |
| Increase in net tangible book value per share attributable to new investors participating in this offering |     | $ |  0.07 |   |     |   |      |
| Pro forma as adjusted net tangible book value per share after this offering                                |     |   |       |   |     | $ | 0.16 |
| Dilution per share to new investors participating in this offering                                         |     |   |       |   |     | $ | 3.04 |

The foregoing discussion and table does not take into account further dilution to investors in this offering that could occur upon the exercise of outstanding options and warrants having a per share exercise price less than the public offering price per share in this Primary Offering.

<div align='center'>28

MARKET PRICE OF AND DIVIDENDS ON THE COMPANY’S

COMMON EQUITY AND RELATED STOCKHOLDER MATTERS</div>

Market Information

Our Common Stock is quoted on the OTC Pink under the symbol “RVRC”. Over-the-counter market quotations reflect inter-dealer prices, without retail mark-up, mark-down or commissions and may not necessarily represent actual transactions. On February